• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

FAECALIBACTERIUM PRAUSNITZII

TNF inhibitors and the microbiome

August 24, 2018Autoimmune Diseases, Microbiome, Vizit Graphs
TNF inhibitors and the microbiome

Study microbiota of patients treated with TNF inhibitors with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

STAPHYLOCOCCUS AUREUS PSEUDOMONAS AERUGINOSA TH17 CELLS NEURODEGENERATIVE DISORDERS CD4 INFLAMMATION CANCER CELL DIFFERENTIATION 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE IL17A CELL PROLIFERATION PARKINSON DISEASE APOPTOTIC PROCESS ALZHEIMER'S DISEASE CELL DEATH STREPTOCOCCUS PNEUMONIAE SOD1 DIABETES MELLITUS RHEUMATOID ARTHRITIS RECEPTOR ERBB-2 REMICADE CTLA4 INSULIN IMMUNE RESPONSE DOXORUBICIN LISTERIA MONOCYTOGENES TP53 ESCHERICHIA COLI CASP3 BREAST CANCER CANDIDA ALBICANS IL6 PORPHYROMONAS GINGIVALIS CLOSTRIDIUM DIFFICILE ANGIOGENESIS IFNG CELL DIVISION AUTOPHAGY HELICOBACTER PYLORI METFORMIN TNF FOXP3 IL23A AGING

© 2020 Biovista Vizit All Rights Reserved.